(New page: {{BioPsy}} {{Drugbox| |IUPAC_name = ? | image = Dibenzepin.png | width=120 | CAS_number=4498-32-2 | ATC_prefix=N06 | ATC_suffix=AA08 | ATC_supplemental= | PubChem=9419 | DrugBank= | C=18 |...) |
m (replacing category per Template:Category redirect) |
||
| Line 24: | Line 24: | ||
{{Antidepressants}} |
{{Antidepressants}} |
||
| − | [[Category:Tricyclic |
+ | [[Category:Tricyclic antidepressant drugs]] |
Latest revision as of 04:10, 14 November 2010
Assessment |
Biopsychology |
Comparative |
Cognitive |
Developmental |
Language |
Individual differences |
Personality |
Philosophy |
Social |
Methods |
Statistics |
Clinical |
Educational |
Industrial |
Professional items |
World psychology |
Biological: Behavioural genetics · Evolutionary psychology · Neuroanatomy · Neurochemistry · Neuroendocrinology · Neuroscience · Psychoneuroimmunology · Physiological Psychology · Psychopharmacology (Index, Outline)
|
Dibenzepin chemical structure | |
| ? IUPAC name | |
| CAS number 4498-32-2 |
ATC code |
| PubChem 9419 |
DrugBank [1] |
| Chemical formula | {{{chemical_formula}}} |
| Molecular weight | 295.379 |
| Bioavailability | ? |
| Metabolism | Hepatic |
| Elimination half-life | ? |
| Excretion | Renal |
| Pregnancy category | ? |
| Legal status | ? |
| Routes of administration | Oral |
Dibenzepin (Noveril®) is a muscarinic antagonist. It is indicated for use as an antidepressant.
| This page uses Creative Commons Licensed content from Wikipedia (view authors). |